Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calculating Wall Shear Stress in Pulmonary Veins of Infants Using Cardiac Magnetic Resonance Imaging
NCT06440408Phase 1Recruiting
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Sep 2024
- Primary completion
- Jun 2027
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ferumoxytol in pulmonary vein stenosis (PVS), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Wall Shear Stress level at 12 months. Started Sep 2024; status: recruiting.
02
Drugs
ferumoxytol
03
Conditions
pulmonary vein stenosis (PVS)
Beyond the preview
Go deeper on NCT06440408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440408.